Search results for "From ACP Internist Weekly"
Guideline suggests prescription medications when lifestyle change ineffective for weight loss
For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://gastroenterology.acponline.org/archives/2022/10/28/6.htm
28 Oct 2022
About one-third of Americans with HCV had evidence of viral clearance in past decade
The highest proportion of hepatitis C virus (HCV) cure or clearance among all age groups and payers was 49% among commercially insured patients ages 60 years and older, a study found.
https://gastroenterology.acponline.org/archives/2023/07/28/6.htm
28 Jul 2023
Gastric bypass benefits persist over long-term follow-up, study finds
The authors said their study shows long-term durability of weight loss after bariatric surgery with Roux-en-Y gastric bypass, as well as related improvements in type 2 diabetes, hypertension, and lipid levels.
https://gastroenterology.acponline.org/archives/2017/10/27/7.htm
27 Oct 2017
AGA clinical practice update offers guidance on PPI deprescribing
All patients taking a proton-pump inhibitor (PPI) should have a regular review and documentation of ongoing indications for use, which should be the responsibility of the primary care clinician, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/02/25/6.htm
25 Feb 2022
CDC calls for all U.S. adults to be screened for hepatitis B
All adults should undergo triple-panel screening at least once in their lives, and screening should be repeated during the first trimester of every pregnancy, the CDC said.
https://gastroenterology.acponline.org/archives/2023/03/24/6.htm
24 Mar 2023
ACG updates, reaffirms guidelines on evaluation, management of patients with celiac disease
The diagnostic approach to celiac disease in adults using serological and histologic data remains unchanged from the American College of Gastroenterology's (ACG) 2013 clinical guidelines.
https://gastroenterology.acponline.org/archives/2023/01/27/6.htm
27 Jan 2023
Studies show mixed results for artificial intelligence during colonoscopies
One study found a higher adenoma detection rate in patients who underwent computer-aided detection compared to standard colonoscopy, while another found that artificial intelligence did not improve identification of advanced colorectal neoplasias.
https://gastroenterology.acponline.org/archives/2023/09/22/6.htm
22 Sep 2023
Response to linaclotide for IBS constipation can still appear after four weeks
An industry-funded analysis of four randomized trials of linaclotide for irritable bowel syndrome (IBS) with constipation found that improvement in abdominal and bowel symptoms occurred after four weeks of treatment in 1 in 6 and 1 in 10 patients, respectively.
https://gastroenterology.acponline.org/archives/2022/12/23/6.htm
23 Dec 2022
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://gastroenterology.acponline.org/archives/2022/11/18/6.htm
18 Nov 2022
Long-term PPI use associated with higher incidence of dementia
While patients who took proton-pump inhibitors (PPIs) from mid- to late life had a modestly higher risk of dementia in late life versus nonusers, shorter-term use was not associated with increased risk.
https://gastroenterology.acponline.org/archives/2023/08/25/7.htm
25 Aug 2023